JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazagne, L.
Right arrow Articles by Dabernat, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazagne, L.
Right arrow Articles by Dabernat, H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 1998, p. 3629-3635, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Molecular Epidemiology of Ampicillin-Resistant Non-beta -Lactamase-Producing Haemophilus influenzae

Louise Gazagne,1 Catherine Delmas,1 Edouard Bingen,2 and Henri Dabernat1,*

Laboratoire de Microbiologie, Centre Hospitalier Universitaire Purpan, Toulouse,1 and Laboratoire de Microbiologie, Centre Hospitalier Universitaire R. Debré, Paris,2 France

Received 14 April 1998/Returned for modification 1 July 1998/Accepted 7 September 1998

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Resistance to ampicillin without beta -lactamase production is not a frequent occurrence among Haemophilus influenzae strains. This kind of resistance is encountered in unencapsulated strains isolated from bronchial secretions and ear, nose, and throat specimens and is exceptional in H. influenzae type b. We studied 29 of these strains from various areas in France and 2 reference strains. Strains were compared by using ribotyping, arbitarily primed PCR with two primers, and pulsed-field gel electrophoresis. Each technique enabled the identification of 20 to 23 different patterns among the 31 strains. The combination of the different patterns for the strains obtained by the different techniques provided 27 distinct profiles. According to these results, it seems that the clonal propagation of these resistant strains does not occur.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The resistance to antimicrobial agents in Haemophilus influenzae has evolved significantly during the last 20 years. This resistance is essentially to beta -lactam antibiotics as a result of beta -lactamase production. The beta -lactamase involved is frequently of the TEM type and is more rarely of the ROB type (9, 31, 33). About 50% of the strains isolated from patients with meningitis in France produce beta -lactamase (8, 9).

In H. influenzae strains, resistance to beta -lactam antibiotic can also result from the alteration of the antibiotic target: penicillin-binding protein (5, 17, 18, 21, 24, 27, 28, 32). This resistance mode is less frequent. It generally occurs among nonencapsulated strains from nonsystemic specimens (3, 9, 19, 20, 29, 35, 36).

Ampicillin-resistant non-beta -lactamase-producing strains (AMPr beta -) are more difficult to detect because of their low incidence rate. The usual disk diffusion method with a 10- or 25-µg amoxicillin disk does not permit the detection of this mode of resistance. Detection of this kind of resistance (diameter of inhibition, <20 mm, corresponding to an MIC of >= 2 mg/liter) is obtained with a 2-µg ampicillin disk. In France these disks are rarely used because this infrequent mode of resistance is often disregarded. Epidemiological studies with these types of strains are rare (23). We have studied clinical AMPr beta - H. influenzae isolates using molecular biology tools. This allowed us to compare these strains and look for a possible clonal diffusion.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Bacterial strains. In France, H. influenzae strains are sent to the National Center on H. influenzae for different reasons: generally for active surveillance for microbiology laboratories, sometimes for a problem with identification, or when this bacterium is isolated from cerebrospinal fluid. Between 1987 and 1994 about 3,000 strains were sent to the National Center, and 29 of these strains were AMPr beta -. They came from different French metropolitan areas. They have been isolated from various clinical specimens: purulent bronchial secretions; specimens from patients with otitis media, sinusitis, and conjunctivitis; and rhinopharyngeal specimens. The strains have been identified by typical Gram staining appearance, the shapes of the colonies, and their requirements for X factor and V factor. The characteristics of these strains are presented in Table 1. Biotyping was determined by the method of Kilian (15a). Capsular serotyping was performed by slide agglutination with specific antisera (antisera a to f; Difco); all strains were nontypeable. By an agar dilution method with Haemophilus Test Medium (Unipath), the MICs of ampicillin, cefaclor, and cefotaxime were determined. If isolates did not produce beta -lactamase according to the results of a chromogenic cephalosporin test (Nitrocefin; Cefinase; Biomerieux, Marcy l'Etoile, France), if the 2-µg ampicillin disk diffusion test (Becton Dickinson) gave a zone of inhibition of <20 mm, and if the MIC of ampicillin was >= 2 mg/liter, strains were considered AMPr beta -. We simultaneously studied two quality control strains: the ampicillin-susceptible strain H. influenzae ATCC 49766 and the tetracycline-resistant and AMPr beta - strain H. influenzae ATCC 49247. 

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Characteristics of AMPr beta - H. influenzae: patterns obtained by different molecular biology techniquesa

During a period of 2 years, four strains, strains 4, 22, 23, and 31, were isolated from the same child with cystic fibrosis. Two pairs of strains were isolated from two children either at the same time (strains 28 and 29) or at the beginning and the end of an antibiotic treatment (strains 26 and 27).

Methods. (i) Ribotyping (RT). Genomic DNA was extracted by the method of Picard-Pasquier et al. (28a). We used the restriction endonuclease EcoRI (Boehringer Mannheim). After electrophoresis, we transferred the DNA to a nylon membrane (HYBOND-N; Amersham) by the Southern blotting method. Hybridization was performed with an Escherichia coli DNA probe complementary to 16S-23S RNA, and the probe was labelled with digoxigenin. Hybridization signals were detected with the DIG DNA Labelling and Detection Kit (Boehringer Mannheim).

Ribotypes were considered identical only if all bands in their patterns were of the same number and size.

(ii) AP-PCR. Genomic DNA was extracted by the method of Picard-Pasquier et al. (28a). We amplified the DNA with two oligonucleotide primers, 217delta 2 (5'right-arrow3' gCC CCC Agg ggC ACA gT; Genset) and RapIV (5'right-arrow3' TCA CgA TgC A; Genset). Amplification was carried out with a Perkin-Elmer DNA Thermal Cycler (Perkin-Elmer Cetus, Norwalk, Conn.). Randomly amplified products were separated by electrophoresis and were visualized with ethidium bromide.

The patterns generated by arbitarily primed PCR (AP-PCR) were considered identical on the basis of similar numbers and the matching positions of all bands. With this in mind, specific patterns were established on the basis of a single band difference.

(iii) Pulsed-field gel electrophoresis (PFGE). After the colonies were grown, washed, and centrifuged, agarose plugs were made from a 1-1 mixture of 2% low-melting-point agarose and the cell suspension. The plugs were lysed with proteinase K (Boehringer Mannheim) overnight and were then washed with Tris-EDTA buffer. After three washes the agarose plugs were incubated with the restriction enzyme SmaI (Gibco BRL). The resulting DNA fragments were subjected to field inversion gel electrophoresis, and then the bands were visualized with ethidium bromide.

Strains with one band shift were considered to represent unique strains.

Software. The results were analyzed with Taxotron software (P. A. D. Grimont, Institut Pasteur, 1994). The patterns were obtained after transfer of the data into Mac Draw Pro.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Ampicillin MICs were >= 2 mg/liter for all strains. The cefotaxime MICs were between 0.015 and 0.25 mg/ml, and the cefaclor MICs were between 1 and 32 mg/ml.

All H. influenzae strains were typeable by RT, PFGE, and AP-PCR. The DNA profiles of the same strain generated by each of the three molecular techniques were found to be stable and reproducible on two or more separate occasions.

RT. The RT patterns obtained with EcoRI had 10 to 13 bands ranging between 1 and 15 kb (Fig. 1). The output repeatedly contained two bands of between 1 and 2 kb.


View larger version (34K):
[in this window]
[in a new window]
  		FIG. 1.   Patterns for AMPr beta - H. influenzae strains obtained by RT. The dendrogram and RT patterns of EcoRI-restricted H. influenzae DNA were analyzed with Taxotron software. Strains 1 to 31 are described in Table 1. S, strains; D, areas.

Among the 29 strains of H. influenzae, digestion with EcoRI, gave 23 RT patterns.

AP-PCR. AP-PCR with two different primers, 217delta 2 and RapIV (Fig. 2 and 3, respectively), gave 21 and 23 independent patterns, respectively. Both primers yielded 2 to 11 amplified products ranging in size from 0.2 to 2 kb.


View larger version (28K):
[in this window]
[in a new window]
  		FIG. 2.   Patterns for AMPr beta - H. influenzae strains obtained by AP-PCR with primer 217delta 2. The dendrogram and AP-PCR profiles obtained with primer 217delta 2 of H. influenzae were analyzed with Taxotron software. Strains 1 to 31 are described in Table 1. The Molecular Weight III marker was from Boehringer Mannheim. S, strains; D, areas.


View larger version (22K):
[in this window]
[in a new window]
  		FIG. 3.   Patterns for AMPr beta - H. influenzae strains obtained by AP-PCR with primer RapIV. The dendrogram and AP-PCR profiles obtained with primer RapIV of H. influenzae were analyzed with Taxotron software. Strains 1 to 31 are described in Table 1. The Molecular Weight III marker was from Boehringer Mannheim. S, strains; D, areas.

The 21 different patterns obtained with primer 217delta 2 (Fig. 2) are very heterogeneous; nevertheless, several groups could be identified.

The 23 patterns obtained with RapIV (Fig. 3) were extremely varied. Among the 31 strains, 12 were weakly linked.

PFGE. PFGE with SmaI restriction endonuclease digestion generated 20 unique DNA fragment patterns (Fig. 4).


View larger version (24K):
[in this window]
[in a new window]
  		FIG. 4.   Patterns for AMPr beta - H. influenzae strains obtained by PFGE. The dendrogram and PFGE profiles of SmaI-digested DNA of H. influenzae were analyzed with Taxotron software. Strains 1 to 31 are described in Table 1. The bacteriophage lambda Ladder PFG Marker was obtained from Biolabs. S, strains; D, areas.

The patterns were easy to interpret, with 5 to 10 bands in each one.

Using these different techniques, we spotted several groups of strains, as described Table 2.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Different strain groups obtained by four molecular biology techniquesa

Overall analysis. We assigned a letter to each different profile obtained by each technique. We obtained a code of four letters. We assigned a Roman numeral to each different code. When strains had the same Roman numeral, they had the same profile as determined by the four techniques. Twenty-seven different profiles were identified. One group consists of four strains (strains 1, 7, 24, and 25), and another group consists of two strains (strains 26 and 27). All the other strains had a unique code.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

H. influenzae AMPr beta - strains are not frequently encountered. According to the accepted limit of the MIC, their incidence varies. The frequencies of occurrence of resistant strains are <1 to 2.5% (MICs, >= 2 mg/liter) in Canada and the United States (1, 2, 5, 10, 11, 34), 5 to 7% (MICs, >= 1 mg/liter) in the United Kingdom (29-31), <1 to 7% (MICs, >= 1 or >= 2 mg/liter) in Australia (3, 6), 13% (MICs, >= 1 mg/liter) in Greece (14), 1% (MICs, >= 2 mg/liter) in France (7), and 0.3% (MICs, >= 4 mg/liter) in an international study (15). This variability in the incidence of AMPr beta - strains illustrates the difficulties encountered in highlighting this kind of resistance. A 20-µg ampicillin disk cannot detect AMPr beta - H. influenzae strains. An inhibition zone diameter of <20 mm obtained with a 2-µg ampicillin disk would indicate the need to measure the ampicillin MIC.

Although the MICs of other beta -lactam antibiotics were increased (2, 13, 22), the clinical consequences of these types of strains did not seem to be very important. Three infections with AMPr beta - H. influenzae were described. Two cases, a case of endocarditis (18) and a case of septicemia (27), were due to a serotype b strain; one case (a case of meningitis) was caused by a nonserotypeable strain (22).

Studies of the epidemiology of nontypeable strains prove the important heterogenieity of these strains (4, 12, 16, 26). This heterogenieity is the same as that in AMPr beta - H. influenzae strains, and Mendelman et al. (23) have deduced that this resistance originated long ago. Our results agree with their conclusions. The four techniques that we used gave 27 different profiles for 31 strains.

In our study, using these different techniques we spotted several groups of strains. The most important was made up of strains 1 (ATCC 49247), 7, 15, 24, 25, and ±19. These strains came from various areas, and their resistance to antibiotics was heterogeneous. Five strains were biotype III, and one was biotype IV. Their only similarity was their biotype, and biotype III is very common among nontypeable H. influenzae strains.

The second group was consisted of two strains that exhibited the same biotype. Strain 11 was paired with strain 2 (ATCC 49766) by all methods except AP-PCR with primer RapIV; by this technique strain 11 was identical to strain 14, but their antibiotic susceptibilities, origins, and biotypes were different. It seems that the different patterns obtained did not permit us to make a deduction about the resistance of strain 11 (ATCC 49766 is ampicillin susceptible).

The third group consisted of strains 26, 27, and ±14. Strains 26 and 27 were isolated from the rhinopharynx of a 9-month-old child at the beginning and at the end of antibiotic treatment and were absolutely identical. Strain 14 had the same biotype as strains 26 and 27 but it was isolated in a different geographic area and had an antibiotic susceptibility profile different from those of strains 26 and 27.

The fourth group consisted of a couple of identical strains (strains 28 and 29) simultaneously isolated from the eye and the rhinopharynx, respectively, of a 2-year-old child. The strains were identical by all techniques except AP-PCR with primer RapIV (one band difference). We cannot explain this result.

The fifth group consisted of strains that came from the same hospital (strains 4, 5, ±22, ±23, and ±31). All five strains had the same antibiotic susceptibility profiles and biotypes and were isolated from two patients with cystic fibrosis. Four of the strains (strains 4, 22, 23, and 31) came from an 18-year-old patient and were isolated over a period of 2 years. By our methods, these four strains had similar profiles, permitting us to presume a persistent infection with the same AMPr beta - H. influenzae strain. Nevertheless, this strain varied a little during this period. The other strain, strain 5, came from a 5-year-old child with cystic fibrosis and was linked to the four previous strains according to its profile. A horizontal transmission of this strain seems possible.

The results obtained by the molecular biology techniques that we used were reproducible, and all techniques gave the same number of patterns. However, our impression is that AP-PCR and PFGE (this technique showed that the four strains from the same cystic fibrosis patient were identical) are more adaptable than RT to epidemiological studies of H. influenzae. Indeed, RT is more fastidious and time-consuming than AP-PCR and PFGE.

By four molecular techniques, we highlighted 27 different profiles among the 31 strains tested. The important number of patterns obtained by these methods, unlike the numbers of patterns obtained for multidrug-resistant Streptococcus pneumoniae strains (25), allowed us to eliminate the hypothesis of the clonal propagation of AMPr beta - H. influenzae strains in this study.

Few studies on the virulence of AMPr beta - H. influenzae strains have been published. It seemed important to clarify the place of this type of H. influenzae in pathology and to suggest a consensus addressing the possible problem of failure of treatment. Moreover, a longer epidemiological study to specify their origins and their diffusion modes should be considered.

    ACKNOWLEDGMENTS

We thank P. Berche for kindly providing some of the strains for this study and G. Chabanon for allowing us to use his technical facilities. We gratefully acknowledge the technical assistance of J. L. Dournes, R. Pelissier, N. Brahimi, and M. Seguy, and we extend our thanks to all the biologists who sent their strains to the National Center on H. influenzae. We also thank the pharmaceutical companies SmithKline Beecham, Roche, and Roussel Diamant for personal support to L.G.

    FOOTNOTES

* Corresponding author. Mailing address: Laboratoire de Microbiologie, Hôpital PURPAN, Place du Dr. Baylac, 31059 Toulouse Cedex, France. Phone: 33-5 61 77 23 57. Fax: 33-5 61 77.23 33. E-mail: dabernat.h{at}chu-toulouse.fr.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1. Barry, A. L., P. C. Fuchs, J. H. Jorgensen, F. C. Tenover, S. D. Allen, D. J. Hardy, and J. C. McLaughlin. 1993. Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests. J. Clin. Microbiol. 31:751-753[Abstract/Free Full Text].
2. Barry, A. L., P. C. Fuchs, and M. A. Pfaller. 1993. Susceptibilities of beta -lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid. Antimicrob. Agents Chemother. 37:14-18[Abstract/Free Full Text].
3. Bell, S. M., and D. Plowman. 1980. Mechanisms of ampicillin resistance in Haemophilus influenzae from respiratory tract. Lancet i:279-280.
4. Bruce, K. D., and J. Z. Jordens. 1991. Characterization of noncapsulate Haemophilus influenzae by whole-cell polypeptide profiles, restriction endonuclease analysis, and rRNA gene restriction patterns. J. Clin. Microbiol. 29:291-296[Abstract/Free Full Text].
5. Clairoux, N., M. Picard, A. Brochu, N. Rousseau, P. Gourde, D. Beauchamp, T. R. Parr, M. G. Bergeron, and F. Malouin. 1992. Molecular basis of the non-beta -lactamase-mediated resistance to beta -lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob. Agents Chemother. 36:1504-1513[Abstract/Free Full Text].
6. Collignon, P. J., J. M. Bell, S. J. Macinness, G. L. Gilbert, M. Toohey, and The Australian Group for Antimicrobial Resistance (AGAR). 1992. A national collaborative study of resistance to antimicrobial agents in Haemophilus influenzae in Australian hospitals. J. Antimicrob. Chemother. 30:153-163[Abstract/Free Full Text].
7. Dabernat, H. 1991. Centre National de Référence pour Haemophilus influenzae: rapport d'activitiés, année 1990. Bull. Epidemiol. Hebd. 33:140-141.
8. Dabernat, H., and C. Delmas. 1996. Activité du Centre National de Référence pour Haemophilus influenzae, bilan 1994-1995. Les débuts de l'après vaccination. Med. Mal. Infect. 26:698-703.
9. Dabernat, H., M. Seguy, and C. Delmas. 1994. Situation en 1993 de la résistance aux antibiotiques chez Haemophilus influenzae en France (bilan du Centre National de Référence pour H. influenzae). Med. Mal. Infect. 24:1244-1247.
10. Doern, G. V., and R. N. Jones. 1988. Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 32:1747-1753[Free Full Text].
11. Doern, G. V., J. H. Jorgensen, C. Thornsberry, D. A. Preston, T. Tubert, J. S. Redding, and L. A. Maher. 1988. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob. Agents Chemother. 32:180-185[Abstract/Free Full Text].
12. Fusté, M. C., M. A. Pineda, J. Palomar, M. Vias, and J. G. Lorén. 1996. Clonality of multidrug-resistant nontypeable strains of Haemophilus influenzae. J. Clin. Microbiol. 34:2760-2765[Abstract].
13. Gutmann, L., R. Williamson, E. Collatz, and J. F. Acar. 1988. Mechanisms of beta-lactam resistance in Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis. 7:610-615[Medline].
14. Heelan, J. S., D. Chesney, and G. Guadano. 1992. Investigation of ampicillin-intermediate strains of Haemophilus influenzae using the disk procedure and current National Committee for Clinical Laboratory Standards guidelines. J. Clin. Microbiol. 30:1674-1677[Abstract/Free Full Text].
15. Kayser, F. H., G. Morenzoni, and P. Santanam. 1990. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis. 9:810-817[Medline].
15a. Kilian, M. A. 1976. A taxonomic study of the genus Haemophilus with the proposal of a new species. J. Gen. Microbiol. 93:9-62[Medline].
16. Loos, B. G., J. M. Bernstein, D. M. Dryja, T. F. Murphy, and D. P. Dickinson. 1989. Determination of the epidemiology and transmission of nontypeable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints. Infect. Immun. 57:2751-2757[Abstract/Free Full Text].
17. Malouin, F., and L. E. Bryan. 1986. Modification of penicillin-binding proteins as mechanisms of beta -lactam resistance. Antimicrob. Agents Chemother. 30:1-5[Free Full Text].
18. Markowitz, S. M. 1980. Isolation of an ampicillin-resistant, non-beta -lactamase-producing strain of Haemophilus influenzae. Antimicrob. Agents Chemother. 17:80-83[Abstract/Free Full Text].
19. Mendelman, P. M. 1992. Targets of the beta -lactam antibiotics, penicillin-binding-proteins, in ampicillin-resistant non-beta -lactamase-producing Haemophilus influenzae. J. Infect. Dis. 165(Suppl. 1):S107-S109.
20. Mendelman, P. M., D. O. Chaffin, C. Clausen, T. L. Stull, C. Needham, J. D. Williams, and A. L. Smith. 1986. Failure to detect ampicillin-resistant, non-beta -lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob. Agents Chemother. 30:274-280[Abstract/Free Full Text].
21. Mendelman, P. M., D. O. Chaffin, and G. Kalaitzoglou. 1990. Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae. J. Antimicrob. Chemother. 25:525-534[Abstract/Free Full Text].
22. Mendelman, P. M., D. O. Chaffin, L. R. Krilov, G. Kalaitzoglou, D. A. Serfass, O. Önay, E. A. Wiley, G. D. Overtuf, and L. G. Rubin. 1990. Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins. J. Infect. Dis. 162:1118-1123[Medline].
23. Mendelman, P. M., D. O. Chaffin, J. M. Musser, R. De Groot, D. A. Serfass, and R. K. Selander. 1987. Genetic and phenotypic diversity among ampicillin-resistant, non-beta -lactamase-producing, nontypeable Haemophilus influenzae isolates. Infect. Immun. 55:2585-2589[Abstract/Free Full Text].
24. Mendelman, P. M., D. O. Chaffin, T. L. Stull, C. E. Rubens, K. D. Mack, and A. L. Smith. 1984. Characterization of non-beta -lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 26:235-244[Abstract/Free Full Text].
25. Munoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306[Medline].
26. Murphy, T. F., K. C. Dudas, J. M. Mylotte, and M. A. Apicella. 1983. A subtyping system for nontypable Haemophilus influenzae based on outer-membrane proteins. J. Infect. Dis. 147:838-846[Medline].
27. Offit, P. A., J. M. Campos, and S. A. Plotkin. 1982. Ampicillin-resistant, beta -lactamase-negative Haemophilus influenzae type b. Pediatrics 69:230-232[Abstract/Free Full Text].
28. Parr, T. R., and L. E. Bryan. 1984. Mechanism of resistance of an ampicillin-resistant, beta -lactamase-negative clinical isolate of Haemophilus influenzae type b to beta -lactam antibiotics. Antimicrob. Agents Chemother. 25:747-753[Abstract/Free Full Text].
28a. Picard-Pasquier, N., M. Ouagued, B. Picard, P. Goulet, and R. Krishnamoorthy. 1989. A simple, sensitive method of analyzing bacterial ribosomal DNA polymorphism. Electrophoresis 10:186-189[Medline].
29. Powell, M., Y. S. Fah, A. Seymour, M. Yuan, and J. D. Williams. 1990. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J. Antimicrob. Chemother. 29:547-554[Abstract/Free Full Text].
30. Powell, M., and D. M. Livermore. 1990. Selection and transformation of non-beta -lactamase-mediated insusceptibility to beta -lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agents. J. Antimicrob. Chemother. 26:741-747[Abstract/Free Full Text].
31. Reid, A. J., I. N. Simpson, P. H. Harder, and S. G. B. Aymes. 1987. Ampicillin resistance in Haemophilus influenzae: identification of resistance mechanisms. J. Antimicrob. Chemother. 20:645-656[Abstract/Free Full Text].
32. Serfass, D. A., P. M. Mendelman, D. O. Chaffin, and C. A. Needham. 1986. Ampicillin resistance and penicillin-binding proteins of Haemophilus influenzae. J. Gen. Microbiol. 132:2855-2861[Medline].
33. Thomas, W. J., J. W. Mc Reynolds, C. R. Mock, and D. W. Bailey. 1974. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet i:313.
34. Tremblay, L. D., J. L'Ecuyer, P. Provencher, and M. G. Bergeron. 1990. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Can. Med. Assoc. J. 143:895-901[Abstract].
35. Williams, J. D., and F. Moosdeen. 1986. Antibiotic resistance in Haemophilus influenzae: epidemiology, mechanisms, and therapeutic possibilities. Rev. Infect. Dis. 8(Suppl. 5):S555-S561.
36. Woolfrey, B. F., R. T. Lally, and M. N. Ederer. 1987. Evaluation of Haemophilus type b systemic isolates for beta -lactamase and non-beta -lactamase mediated ampicillin resistance and for susceptibility to other antimicrobial agents. Am. J. Clin. Pathol. 88:361-365[Medline].

Journal of Clinical Microbiology, December 1998, p. 3629-3635, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazagne, L.
Right arrow Articles by Dabernat, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazagne, L.
Right arrow Articles by Dabernat, H.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS